文献速递淋巴瘤造血干细胞移植与细胞治疗

未婚或低教育程度套细胞淋巴瘤患者移植率低致生存更差

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival.
PubMed 文献 · Blood Adv · 2021-01-01

瑞典淋巴瘤登记研究纳入2000-2014年诊断的18-65岁套细胞淋巴瘤患者369例,148例(40%)在诊断后18个月内未接受自体造血干细胞移植。未婚、离异、低教育程度及有合并症者接受移植的可能性更低;接受移植与全因死亡率降低相关(HR=0.58,95%CI:0.40-0.85),移植相关死亡率低(2%)。

要点

  • 40%的套细胞淋巴瘤患者诊断后18个月内未接受自体移植。
  • 未婚、离异、低教育程度及合并症者接受移植的可能性更低。
  • 接受移植与全因死亡率降低相关(HR=0.58,95%CI:0.40-0.85)。

核心结论

  • 未接受自体移植的套细胞淋巴瘤患者死亡率更高,且某些社会群体存在移植不足。

研究设计与样本

  • 基于瑞典淋巴瘤登记的前瞻性队列研究,纳入2000-2014年诊断的18-65岁套细胞淋巴瘤患者369例。

主要发现

  • 369例患者中148例(40%)在诊断后18个月内未接受自体造血干细胞移植。
  • 与已婚患者相比,未婚和离异患者接受移植的可能性更低,低教育程度和合并症患者同样更低。
  • 接受自体移植与全因死亡率降低相关(HR=0.58,95%CI:0.40-0.85)。
  • 移植相关死亡率为2%。

关键数值与推荐

  • 接受自体移植者全因死亡风险比为0.58(95%CI:0.40-0.85)。
  • 移植相关死亡率为2%。

临床怎么用

  • 应关注未婚、离异、低教育程度及合并症患者的移植可及性,改善支持治疗以提高移植耐受性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is unknown how many mantle cell lymphoma (MCL) patients undergo consolidation with autologous hematopoietic cell transplantation (AHCT), and the reasons governing the decision, are also unknown. The prognostic impact of omitting AHCT is also understudied. We identified all MCL patients diagnosed from 2000 to 2014, aged 18 to 65 years, in the Swedish Lymphoma Register. Odds ratios (ORs) and 95% confidence intervals (CIs) from logistic regression models were used to compare the likelihood of AHCT within 18 months of diagnosis. All-cause mortality was compared between patients treated with/without AHCT using hazard ratios (HRs) and 95% CIs estimated from Cox regression models. Probabilities of being in each of the following states: alive without AHCT, alive with AHCT, dead before AHCT, and dead after AHCT, were estimated over time from an illness-death model. Among 369 patients, 148 (40%) were not treated with AHCT within 18 months. Compared with married patients, never married and divorced patients had lower likelihood of undergoing AHCT, as had patients with lower educational level, and comorbid patients. Receiving AHCT was associated with reduced all-cause mortality (HR = 0.58, 95% CI: 0.40-0.85). Transplantation-related mortality was low (2%). MCL patients not receiving an AHCT had an increased mortality rate, and furthermore, an undue concern about performing an AHCT in certain societal groups was seen. Improvements in supportive functions potentially increasing the likelihood of tolerating an AHCT and introduction of more tolerable treatments for these groups are needed.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Glimelius I, Smedby KE, Albertsson-Lindblad A, et al. Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival. Blood Adv. 2021. PMID: 33710334. doi:10.1182/bloodadvances.2020003645

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。